Manufacturer |
GENWAY
|
Category |
|
Type |
Antibody |
Specific against |
other |
Clone |
RA3-6B2 |
Applications |
FC |
Amount |
25 TESTS |
Item no. |
20-783-310039 |
eClass 6.1 |
32160702 |
eClass 9.0 |
32160702 |
Available |
|
Genway ID: |
GWB-784C4B |
Specificity: |
CD45RNCBI |
Gene ID: |
19264 |
Specificity: |
CD45R |
Clone: |
RA3-6B2 |
Preparation: |
Purified IgG prepared by affinity chromatography on Protein G |
|
Preservative Stabilisers: |
| 0. 09%Sodium Azide1%Bovine Serum Albumin Reconstitution: Reconstitute with 0. 25 ml distilled water Suggested |
Flow Cytometry: |
Use 10ul of the suggested working dilution to label 106 cells in 100ul. The Fc region of monoclonal antibodies may bind non-specifically to cells expressing low affinity fc receptors. This may be reduced by using SeroBlock FcR (/). Suggested |
Dilution: |
Flow Cytometry - Neat |
Function: |
Required for T-cell activation through the antigen receptor. The first PTPase domain has enzymatic activity while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation recruits an dephosphorylates SKAP1 and FYN. |
Catalytic Activity: |
Protein tyrosine phosphate + H2O = protein tyrosine + phosphate. |
Subunit: |
Binds GANAB and PRKCSH (By similarity). Interacts with SKAP1. |
Subcellular Location: |
Membrane; Single-pass type I membrane protein. |
Domain: |
The first PTPase domain interacts with SKAP1. |
Ptm: |
Heavily N- and O-glycosylated. |
Disease: |
Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+)SCID) [MIM:608971]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity leukopenia and low or absent antibody levels. Patients with SCID present in infancy with recurrent persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. |
Disease: |
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain. |
Similarity: |
Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily. |
Similarity: |
Contains 2 fibronectin type-III domains. |
Similarity: |
Contains 2 tyrosine-protein phosphatase domains. 1. Spangrude. G. J. et al. (1988) Purification and characterization of mouse hematopoietic stem cells. 2. Coffman. R. (1982) Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. 3. Rosmalen. J. G. M. et al. (2000) Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes. 4. Spangrude. G. J. et al. (1988) Two rare populations of mouse Thy-1lo bone marrow cells repopulate the thymus. 5. Holmes. K. L. et al. (1986) Analysis of neoplasms induced by Cas-Br-M MuLV tumor extracts. 6. Whiteland. J. L. et al. (1995) Immunohistochemical detection of T-Cell subsets and other leucocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J. Histochem. Cytochem. 43: 313-320. 7. Monteith. C. E. et al. (1996) Identification of monoclonal antibodies for immunohistochemical staining of feline B lymphocytes in frozen and formalin fixed paraffin embedded tissues. |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.